首页> 美国卫生研究院文献>The Review of Diabetic Studies : RDS >Erratum to: Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic Pharmacological and Chemical Considerations by Gruzman et al. Rev Diabet Stud 2009 6(1):13-36

【2h】

Erratum to: Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic Pharmacological and Chemical Considerations by Gruzman et al. Rev Diabet Stud 2009 6(1):13-36

机译：勘误：抗糖尿病药物的新靶标单磷酸腺苷激活蛋白激酶（AMPK）：代谢药理和化学方面的考虑综述作者：Gruzman等人Rev Diabet Stud 20096（1）：13-36

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 The Review of Diabetic Studies : RDS
作者
Arie Gruzman; Gali Babai; Shlomo Sasson;
展开▼
作者单位

展开▼
年(卷),期 2009(6),2
年度 2009
页码 130
总页数 1
原文格式 PDF
正文语种
中图分类基础医学;
关键词

相似文献

外文文献

1. Targeting Energy Metabolic and Oncogenic Signaling Pathways in Triple-negative Breast Cancer by a Novel Adenosine Monophosphate-activated Protein Kinase (AMPK) Activator [J] . Kuen-Haur Lee, En-Chi Hsu, Jih-Hwa Guh, The Journal of biological chemistry . 2011,第45期

机译：用新型腺苷一磷酸盐活化蛋白激酶（AMPK）活化剂在三重阴性乳腺癌中靶向能量代谢和致癌信号通路
2. Role of hindbrain adenosine 5′-monophosphate-activated protein kinase (AMPK) in hypothalamic AMPK and metabolic neuropeptide adaptation to recurring insulin-induced hypoglycemia in the male rat [J] . Santosh K. Mandal, Prem K. Shrestha, Fahaad S.H. Alenazi, Neuropeptides: An International Journal . 2017,第期

机译：后脑腺苷5'-单磷酸蛋白激活蛋白激酶（AMPK）在丘脑中的作用和代谢神经肽适应在雄性大鼠中重复胰岛素诱导的低血糖
3. Optimization of Metabolic and Renal Clearance in a Series of Indole Acid Direct Activators of 5 '-Adenosine Monophosphate-Activated Protein Kinase (AMPK) [J] . Edmonds David J., Kung Daniel W., Kalgutkar Amit S., Journal of Medicinal Chemistry . 2018,第6期

机译：一系列吲哚酸直接激活剂的代谢和肾间隙优化5'羟磷酸氨基磷酸盐活化蛋白激酶（AMPK）
4. Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic Pharmacological and Chemical Considerations [O] . Arie Gruzman, Gali Babai, Shlomo Sasson 2009

机译：腺苷单磷酸激活蛋白激酶（AMPK）作为抗糖尿病药物的新目标：代谢药理和化学注意事项的审查。
5. Erratum to: Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations by Gruzman et al., Rev Diabet Stud 2009, 6(1):13-36 [O] . Gruzman, Arie, Babai, Gali, Sasson, Shlomo 2009

机译：勘误：抗糖尿病药物的新靶标单磷酸腺苷激活蛋白激酶（AMPK）：代谢，药理和化学方面的考虑综述，作者：Gruzman等人，Rev Diabet Stud 2009，6（1）：13-36

Erratum to: Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic Pharmacological and Chemical Considerations by Gruzman et al. Rev Diabet Stud 2009 6(1):13-36

著录项

相似文献

相关主题

期刊订阅